Frontpage » Tag » nexavar

News tagged with nexavar

Related topics: cancer drugs , drug



Sorafenib

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

This text uses material from Wikipedia and is available under the GNU Free Documentation License.


Indian drug giant Cipla slashes cancer drug prices

Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".

Medications created May 04, 2012 | popularity 4.9 / 5 (9) | comments 0

India rejects Bayer plea against cheap cancer drug (Update)

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...

Medications created Mar 05, 2013 | popularity 5 / 5 (4) | comments 3

Three 'targeted' cancer drugs raise risk of fatal side effects

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...

Cancer created Feb 06, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Temple researchers show targeted cancer drug may stunt heart's ability to repair itself

Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.

Cardiology created Nov 06, 2012 | popularity 4 / 5 (2) | comments 0 | with audio podcast

Bayer 'disappointed' after losing India patent fight

Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.

Medications created Sep 26, 2012 | popularity not rated yet | comments 0

India licenses generic copy of patented Bayer drug

(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.

Medications created Mar 12, 2012 | popularity 5 / 5 (4) | comments 0

Bayer vows to fight for patent on anti-cancer drug in India

German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.

Medications created Mar 04, 2013 | popularity not rated yet | comments 0

Bayer challenges India cancer drug ruling

German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.

Medications created May 06, 2012 | popularity 5 / 5 (1) | comments 0

FDA panel backs Pfizer drug for kidney cancer

(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.

Medications created Dec 07, 2011 | popularity not rated yet | comments 0